Duman, B. B. Et Al. 2012. Expression of PTEN, Akt, MAPK, p53, p95 for predicting trastuzumab resistance in breast cancer.. 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , (Illinois, United States Of America).

Duman, B. B., Sahin, B., Ergin, M., Zorludemir, S., & Acikalin, A., (2012). Expression of PTEN, Akt, MAPK, p53, p95 for predicting trastuzumab resistance in breast cancer. . 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America

Duman, Berna Et Al. "Expression of PTEN, Akt, MAPK, p53, p95 for predicting trastuzumab resistance in breast cancer.," 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 2012

Duman, Berna B. Et Al. "Expression of PTEN, Akt, MAPK, p53, p95 for predicting trastuzumab resistance in breast cancer.." 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , Illinois, United States Of America, 2012

Duman, B. B. Et Al. (2012) . "Expression of PTEN, Akt, MAPK, p53, p95 for predicting trastuzumab resistance in breast cancer.." 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , Illinois, United States Of America.

@conferencepaper{conferencepaper, author={Berna Bozkurt Duman Et Al. }, title={Expression of PTEN, Akt, MAPK, p53, p95 for predicting trastuzumab resistance in breast cancer.}, congress name={48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)}, city={Illinois}, country={United States Of America}, year={2012}}